{"ticker": "SCTX", "overview": {"cik": "1853921", "ticker": "SCTX", "name": "Scribe Therapeutics, Inc.", "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "sic": "2836", "announcements": [{"form": "SCHEDULE 13G", "date": "2026-08-03", "title": "Form SCHEDULE 13G", "accession": "0001346824-26-000210", "price_sensitive": false}, {"form": "SCHEDULE 13D", "date": "2026-07-30", "title": "Form SCHEDULE 13D", "accession": "0000902664-26-003281", "price_sensitive": false}, {"form": "SCHEDULE 13D", "date": "2026-07-30", "title": "Form SCHEDULE 13D", "accession": "0000059478-26-000072", "price_sensitive": false}, {"form": "4", "date": "2026-07-29", "title": "Insider transaction", "accession": "0001231919-26-000813", "price_sensitive": false}, {"form": "4", "date": "2026-07-29", "title": "Insider transaction", "accession": "0000947871-26-000734", "price_sensitive": false}, {"form": "4", "date": "2026-07-29", "title": "Insider transaction", "accession": "0000947871-26-000733", "price_sensitive": false}, {"form": "SCHEDULE 13D", "date": "2026-07-29", "title": "Form SCHEDULE 13D", "accession": "0000947871-26-000732", "price_sensitive": false}, {"form": "4", "date": "2026-07-29", "title": "Insider transaction", "accession": "0001739090-26-000010", "price_sensitive": false}, {"form": "4", "date": "2026-07-28", "title": "Insider transaction", "accession": "0000902664-26-003270", "price_sensitive": false}, {"form": "4", "date": "2026-07-28", "title": "Insider transaction", "accession": "0002147277-26-000003", "price_sensitive": false}, {"form": "4", "date": "2026-07-27", "title": "Insider transaction", "accession": "0001781292-26-000007", "price_sensitive": false}, {"form": "4", "date": "2026-07-27", "title": "Insider transaction", "accession": "0002127814-26-000004", "price_sensitive": false}, {"form": "4", "date": "2026-07-27", "title": "Insider transaction", "accession": "0001282930-26-000004", "price_sensitive": false}, {"form": "4", "date": "2026-07-27", "title": "Insider transaction", "accession": "0002130384-26-000004", "price_sensitive": false}, {"form": "4", "date": "2026-07-27", "title": "Insider transaction", "accession": "0002075052-26-000004", "price_sensitive": false}, {"form": "4", "date": "2026-07-27", "title": "Insider transaction", "accession": "0002127908-26-000004", "price_sensitive": false}, {"form": "4", "date": "2026-07-27", "title": "Insider transaction", "accession": "0000902664-26-003254", "price_sensitive": false}, {"form": "8-K", "date": "2026-07-27", "title": "Material event", "accession": "0001193125-26-318263", "price_sensitive": true}, {"form": "S-8", "date": "2026-07-27", "title": "Employee share plan", "accession": "0001193125-26-316529", "price_sensitive": false}, {"form": "424B4", "date": "2026-07-27", "title": "Form 424B4", "accession": "0001193125-26-316503", "price_sensitive": false}, {"form": "FWP", "date": "2026-07-24", "title": "Form FWP", "accession": "0001193125-26-314757", "price_sensitive": false}, {"form": "EFFECT", "date": "2026-07-23", "title": "Form EFFECT", "accession": "9999999995-26-002417", "price_sensitive": false}, {"form": "3", "date": "2026-07-23", "title": "Initial insider holdings", "accession": "0001193125-26-314787", "price_sensitive": false}, {"form": "3", "date": "2026-07-23", "title": "Initial insider holdings", "accession": "0000947871-26-000715", "price_sensitive": false}, {"form": "3", "date": "2026-07-23", "title": "Initial insider holdings", "accession": "0001231919-26-000795", "price_sensitive": false}]}, "description": "", "exchange": "NASDAQ", "stats": {"buy_n": 6, "buy_sum": 71344746.25, "sell_n": 0, "sell_sum": 0, "net": 71344746.25, "insiders": 6, "first_date": "2026-07-23", "last_date": "2026-07-28"}, "metrics": {"ticker": "SCTX", "has_prices": true, "as_of": "2026-08-07", "last": 26.0, "prev_close": 25.41, "change": 0.5899999999999999, "change_pct": 0.02321920503738685, "session_volume": 120180.0, "vwap_5": 23.824673782701957, "vwap_20": 20.93041644458263, "vwap_60": 20.93041644458263, "vwap_250": 20.93041644458263, "high_52w": 26.0, "low_52w": 18.06, "avg_volume_20": 294728.7272727273, "sessions": 11, "market_cap": null}, "trades": [{"id": "13DG-0001346824-26-000210", "src": "13DG", "ticker": "SCTX", "cik": "1853921", "company": "Scribe Therapeutics, Inc.", "company_raw": "Scribe Therapeutics, Inc.", "who": "RA Capital Management, L.P.", "who_key": "RA CAPITAL MANAGEMENT, L.P.", "role": "Substantial holder \u00b7 13G", "person_type": "WHALE", "person_label": "Whales", "action": "DISCLOSURE", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "RA CAPITAL MANAGEMENT, L.P. takes a 9.6% passive stake in SCTX", "source_url": "https://www.sec.gov/Archives/edgar/data/1346824/0001346824-26-000210-index.htm", "trade_date": "2026-08-03", "timestamp": "2026-08-03", "mins": 131926}, {"id": "0000902664-26-003270", "src": "INSIDERS", "ticker": "SCTX", "cik": "1853921", "company": "Scribe Therapeutics, Inc.", "company_raw": "Scribe Therapeutics, Inc.", "who": "Behzad Aghazadeh", "who_key": "Aghazadeh Behzad", "role": "Director, 10% Owner", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 36259761.25, "score": 84.7, "price_sensitive": true, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "3 insiders now buying SCTX", "source_url": "https://www.sec.gov/Archives/edgar/data/1853921/000090266426003270/0000902664-26-003270-index.htm", "trade_date": "2026-07-28", "timestamp": "2026-07-28", "mins": 140566}, {"id": "0001231919-26-000813", "src": "INSIDERS", "ticker": "SCTX", "cik": "1853921", "company": "Scribe Therapeutics, Inc.", "company_raw": "Scribe Therapeutics, Inc.", "who": "AH Bio Fund II, L.P.", "who_key": "AH Bio Fund II, L.P.", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "action": "BUY", "amount": 4999995.0, "score": 59.3, "price_sensitive": true, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Insider cluster: 6 buying SCTX", "source_url": "https://www.sec.gov/Archives/edgar/data/1853921/000123191926000813/0001231919-26-000813-index.htm", "trade_date": "2026-07-27", "timestamp": "2026-07-27", "mins": 142006}, {"id": "0000947871-26-000734", "src": "INSIDERS", "ticker": "SCTX", "cik": "1853921", "company": "Scribe Therapeutics, Inc.", "company_raw": "Scribe Therapeutics, Inc.", "who": "Carl L. Gordon", "who_key": "GORDON CARL L", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 15000000.0, "score": 80.1, "price_sensitive": true, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "5 insiders now buying SCTX", "source_url": "https://www.sec.gov/Archives/edgar/data/1853921/000094787126000734/0000947871-26-000734-index.htm", "trade_date": "2026-07-27", "timestamp": "2026-07-27", "mins": 142006}, {"id": "0000947871-26-000733", "src": "INSIDERS", "ticker": "SCTX", "cik": "1853921", "company": "Scribe Therapeutics, Inc.", "company_raw": "Scribe Therapeutics, Inc.", "who": "Orbimed Advisors LLC", "who_key": "ORBIMED ADVISORS LLC", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 15000000.0, "score": 80.1, "price_sensitive": true, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Insider cluster: 4 buying SCTX", "source_url": "https://www.sec.gov/Archives/edgar/data/1853921/000094787126000733/0000947871-26-000733-index.htm", "trade_date": "2026-07-27", "timestamp": "2026-07-27", "mins": 142006}, {"id": "0001739090-26-000010", "src": "INSIDERS", "ticker": "SCTX", "cik": "1853921", "company": "Scribe Therapeutics, Inc.", "company_raw": "Scribe Therapeutics, Inc.", "who": "Jennifer A. Doudna", "who_key": "Doudna Jennifer A", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "10% owner files routine paperwork on SCTX \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1853921/000173909026000010/0001739090-26-000010-index.htm", "trade_date": "2026-07-27", "timestamp": "2026-07-27", "mins": 142006}, {"id": "13DG-0000947871-26-000732", "src": "13DG", "ticker": "SCTX", "cik": "1853921", "company": "Scribe Therapeutics, Inc.", "company_raw": "Scribe Therapeutics, Inc.", "who": "Orbimed Advisors LLC", "who_key": "ORBIMED ADVISORS LLC", "role": "Substantial holder \u00b7 13D", "person_type": "WHALE", "person_label": "Whales", "action": "DISCLOSURE", "amount": 0.0, "score": 0.0, "price_sensitive": true, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "ORBIMED ADVISORS LLC takes a 7.2% activist stake in SCTX", "source_url": "https://www.sec.gov/Archives/edgar/data/1055951/0000947871-26-000732-index.htm", "trade_date": "2026-07-29", "timestamp": "2026-07-27", "mins": 142006}, {"id": "13DG-0000902664-26-003281", "src": "13DG", "ticker": "SCTX", "cik": "1853921", "company": "Scribe Therapeutics, Inc.", "company_raw": "Scribe Therapeutics, Inc.", "who": "Avoro Capital Advisors LLC", "who_key": "Avoro Capital Advisors LLC", "role": "Substantial holder \u00b7 13D", "person_type": "WHALE", "person_label": "Whales", "action": "DISCLOSURE", "amount": 0.0, "score": 0.0, "price_sensitive": true, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Avoro Capital Advisors LLC takes a 13.78% activist stake in SCTX", "source_url": "https://www.sec.gov/Archives/edgar/data/1633313/0000902664-26-003281-index.htm", "trade_date": "2026-07-30", "timestamp": "2026-07-24", "mins": 146326}, {"id": "13DG-0000059478-26-000072", "src": "13DG", "ticker": "SCTX", "cik": "1853921", "company": "Scribe Therapeutics, Inc.", "company_raw": "Scribe Therapeutics, Inc.", "who": "ELI Lilly & Co", "who_key": "ELI LILLY & Co", "role": "Substantial holder \u00b7 13D", "person_type": "WHALE", "person_label": "Whales", "action": "DISCLOSURE", "amount": 0.0, "score": 0.0, "price_sensitive": true, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "ELI LILLY & Co takes a 7.3% activist stake in SCTX", "source_url": "https://www.sec.gov/Archives/edgar/data/59478/0000059478-26-000072-index.htm", "trade_date": "2026-07-30", "timestamp": "2026-07-23", "mins": 147766}, {"id": "0001781292-26-000007", "src": "INSIDERS", "ticker": "SCTX", "cik": "1853921", "company": "Scribe Therapeutics, Inc.", "company_raw": "Scribe Therapeutics, Inc.", "who": "Svetlana Lucas", "who_key": "Lucas Svetlana", "role": "Chief Business Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "BUY", "amount": 45000.0, "score": 38.7, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "C-suite exec buys $45K of SCTX", "source_url": "https://www.sec.gov/Archives/edgar/data/1853921/000178129226000007/0001781292-26-000007-index.htm", "trade_date": "2026-07-23", "timestamp": "2026-07-23", "mins": 147766}, {"id": "0001282930-26-000004", "src": "INSIDERS", "ticker": "SCTX", "cik": "1853921", "company": "Scribe Therapeutics, Inc.", "company_raw": "Scribe Therapeutics, Inc.", "who": "Carl L. Gordon", "who_key": "GORDON CARL L", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on SCTX \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1853921/000128293026000004/0001282930-26-000004-index.htm", "trade_date": "2026-07-23", "timestamp": "2026-07-23", "mins": 147766}, {"id": "0002130384-26-000004", "src": "INSIDERS", "ticker": "SCTX", "cik": "1853921", "company": "Scribe Therapeutics, Inc.", "company_raw": "Scribe Therapeutics, Inc.", "who": "James Dean Watson", "who_key": "Watson James Dean", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on SCTX \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1853921/000213038426000004/0002130384-26-000004-index.htm", "trade_date": "2026-07-23", "timestamp": "2026-07-23", "mins": 147766}, {"id": "0002075052-26-000004", "src": "INSIDERS", "ticker": "SCTX", "cik": "1853921", "company": "Scribe Therapeutics, Inc.", "company_raw": "Scribe Therapeutics, Inc.", "who": "Joshua Bleharski", "who_key": "Bleharski Joshua", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on SCTX \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1853921/000207505226000004/0002075052-26-000004-index.htm", "trade_date": "2026-07-23", "timestamp": "2026-07-23", "mins": 147766}, {"id": "0002127908-26-000004", "src": "INSIDERS", "ticker": "SCTX", "cik": "1853921", "company": "Scribe Therapeutics, Inc.", "company_raw": "Scribe Therapeutics, Inc.", "who": "David Parrot", "who_key": "Parrot David", "role": "Chief Financial Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "BUY", "amount": 39990.0, "score": 41.9, "price_sensitive": true, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "CFO puts $40K into SCTX", "source_url": "https://www.sec.gov/Archives/edgar/data/1853921/000212790826000004/0002127908-26-000004-index.htm", "trade_date": "2026-07-23", "timestamp": "2026-07-23", "mins": 147766}, {"id": "0000902664-26-003254", "src": "INSIDERS", "ticker": "SCTX", "cik": "1853921", "company": "Scribe Therapeutics, Inc.", "company_raw": "Scribe Therapeutics, Inc.", "who": "Behzad Aghazadeh", "who_key": "Aghazadeh Behzad", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on SCTX \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1853921/000090266426003254/0000902664-26-003254-index.htm", "trade_date": "2026-07-23", "timestamp": "2026-07-23", "mins": 147766}, {"id": "0002147277-26-000003", "src": "INSIDERS", "ticker": "SCTX", "cik": "1853921", "company": "Scribe Therapeutics, Inc.", "company_raw": "Scribe Therapeutics, Inc.", "who": "Brett Staahl", "who_key": "Staahl Brett", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "10% owner files routine paperwork on SCTX \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1853921/000214727726000003/0002147277-26-000003-index.htm", "trade_date": "2026-03-13", "timestamp": "2026-03-13", "mins": 337846}, {"id": "0002127814-26-000004", "src": "INSIDERS", "ticker": "SCTX", "cik": "1853921", "company": "Scribe Therapeutics, Inc.", "company_raw": "Scribe Therapeutics, Inc.", "who": "Benjamin L. Oakes", "who_key": "Oakes Benjamin L.", "role": "President, CEO, Director", "person_type": "CEO", "person_label": "CEOs", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "CEO files routine paperwork on SCTX \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1853921/000212781426000004/0002127814-26-000004-index.htm", "trade_date": "2026-03-13", "timestamp": "2026-03-13", "mins": 337846}], "recent_buys": [{"id": "0000902664-26-003270", "src": "INSIDERS", "ticker": "SCTX", "cik": "1853921", "company": "Scribe Therapeutics, Inc.", "company_raw": "Scribe Therapeutics, Inc.", "who": "Behzad Aghazadeh", "who_key": "Aghazadeh Behzad", "role": "Director, 10% Owner", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 36259761.25, "score": 84.7, "price_sensitive": true, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "3 insiders now buying SCTX", "source_url": "https://www.sec.gov/Archives/edgar/data/1853921/000090266426003270/0000902664-26-003270-index.htm", "trade_date": "2026-07-28", "timestamp": "2026-07-28", "mins": 140566}, {"id": "0000947871-26-000733", "src": "INSIDERS", "ticker": "SCTX", "cik": "1853921", "company": "Scribe Therapeutics, Inc.", "company_raw": "Scribe Therapeutics, Inc.", "who": "Orbimed Advisors LLC", "who_key": "ORBIMED ADVISORS LLC", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 15000000.0, "score": 80.1, "price_sensitive": true, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Insider cluster: 4 buying SCTX", "source_url": "https://www.sec.gov/Archives/edgar/data/1853921/000094787126000733/0000947871-26-000733-index.htm", "trade_date": "2026-07-27", "timestamp": "2026-07-27", "mins": 142006}, {"id": "0000947871-26-000734", "src": "INSIDERS", "ticker": "SCTX", "cik": "1853921", "company": "Scribe Therapeutics, Inc.", "company_raw": "Scribe Therapeutics, Inc.", "who": "Carl L. Gordon", "who_key": "GORDON CARL L", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 15000000.0, "score": 80.1, "price_sensitive": true, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "5 insiders now buying SCTX", "source_url": "https://www.sec.gov/Archives/edgar/data/1853921/000094787126000734/0000947871-26-000734-index.htm", "trade_date": "2026-07-27", "timestamp": "2026-07-27", "mins": 142006}, {"id": "0001231919-26-000813", "src": "INSIDERS", "ticker": "SCTX", "cik": "1853921", "company": "Scribe Therapeutics, Inc.", "company_raw": "Scribe Therapeutics, Inc.", "who": "AH Bio Fund II, L.P.", "who_key": "AH Bio Fund II, L.P.", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "action": "BUY", "amount": 4999995.0, "score": 59.3, "price_sensitive": true, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Insider cluster: 6 buying SCTX", "source_url": "https://www.sec.gov/Archives/edgar/data/1853921/000123191926000813/0001231919-26-000813-index.htm", "trade_date": "2026-07-27", "timestamp": "2026-07-27", "mins": 142006}, {"id": "0002127908-26-000004", "src": "INSIDERS", "ticker": "SCTX", "cik": "1853921", "company": "Scribe Therapeutics, Inc.", "company_raw": "Scribe Therapeutics, Inc.", "who": "David Parrot", "who_key": "Parrot David", "role": "Chief Financial Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "BUY", "amount": 39990.0, "score": 41.9, "price_sensitive": true, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "CFO puts $40K into SCTX", "source_url": "https://www.sec.gov/Archives/edgar/data/1853921/000212790826000004/0002127908-26-000004-index.htm", "trade_date": "2026-07-23", "timestamp": "2026-07-23", "mins": 147766}, {"id": "0001781292-26-000007", "src": "INSIDERS", "ticker": "SCTX", "cik": "1853921", "company": "Scribe Therapeutics, Inc.", "company_raw": "Scribe Therapeutics, Inc.", "who": "Svetlana Lucas", "who_key": "Lucas Svetlana", "role": "Chief Business Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "BUY", "amount": 45000.0, "score": 38.7, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "C-suite exec buys $45K of SCTX", "source_url": "https://www.sec.gov/Archives/edgar/data/1853921/000178129226000007/0001781292-26-000007-index.htm", "trade_date": "2026-07-23", "timestamp": "2026-07-23", "mins": 147766}], "institutional": [{"id": "13DG-0001346824-26-000210", "src": "13DG", "ticker": "SCTX", "cik": "1853921", "company": "Scribe Therapeutics, Inc.", "company_raw": "Scribe Therapeutics, Inc.", "who": "RA Capital Management, L.P.", "who_key": "RA CAPITAL MANAGEMENT, L.P.", "role": "Substantial holder \u00b7 13G", "person_type": "WHALE", "person_label": "Whales", "action": "DISCLOSURE", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "RA CAPITAL MANAGEMENT, L.P. takes a 9.6% passive stake in SCTX", "source_url": "https://www.sec.gov/Archives/edgar/data/1346824/0001346824-26-000210-index.htm", "trade_date": "2026-08-03", "timestamp": "2026-08-03", "mins": 131926}, {"id": "13DG-0000902664-26-003281", "src": "13DG", "ticker": "SCTX", "cik": "1853921", "company": "Scribe Therapeutics, Inc.", "company_raw": "Scribe Therapeutics, Inc.", "who": "Avoro Capital Advisors LLC", "who_key": "Avoro Capital Advisors LLC", "role": "Substantial holder \u00b7 13D", "person_type": "WHALE", "person_label": "Whales", "action": "DISCLOSURE", "amount": 0.0, "score": 0.0, "price_sensitive": true, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Avoro Capital Advisors LLC takes a 13.78% activist stake in SCTX", "source_url": "https://www.sec.gov/Archives/edgar/data/1633313/0000902664-26-003281-index.htm", "trade_date": "2026-07-30", "timestamp": "2026-07-24", "mins": 146326}, {"id": "13DG-0000059478-26-000072", "src": "13DG", "ticker": "SCTX", "cik": "1853921", "company": "Scribe Therapeutics, Inc.", "company_raw": "Scribe Therapeutics, Inc.", "who": "ELI Lilly & Co", "who_key": "ELI LILLY & Co", "role": "Substantial holder \u00b7 13D", "person_type": "WHALE", "person_label": "Whales", "action": "DISCLOSURE", "amount": 0.0, "score": 0.0, "price_sensitive": true, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "ELI LILLY & Co takes a 7.3% activist stake in SCTX", "source_url": "https://www.sec.gov/Archives/edgar/data/59478/0000059478-26-000072-index.htm", "trade_date": "2026-07-30", "timestamp": "2026-07-23", "mins": 147766}, {"id": "13DG-0000947871-26-000732", "src": "13DG", "ticker": "SCTX", "cik": "1853921", "company": "Scribe Therapeutics, Inc.", "company_raw": "Scribe Therapeutics, Inc.", "who": "Orbimed Advisors LLC", "who_key": "ORBIMED ADVISORS LLC", "role": "Substantial holder \u00b7 13D", "person_type": "WHALE", "person_label": "Whales", "action": "DISCLOSURE", "amount": 0.0, "score": 0.0, "price_sensitive": true, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "ORBIMED ADVISORS LLC takes a 7.2% activist stake in SCTX", "source_url": "https://www.sec.gov/Archives/edgar/data/1055951/0000947871-26-000732-index.htm", "trade_date": "2026-07-29", "timestamp": "2026-07-27", "mins": 142006}], "holdings": [], "directors": [], "status": {"status": "listed", "exchange": "NASDAQ", "note": "Currently listed on NASDAQ."}, "corporate_actions": {"status_label": "Listed", "items": [{"action": "RENAME", "reason": null, "counterparty": null, "old_value": "Scribe Therapeutics Inc. - Common Stock", "new_value": "Scribe Therapeutics, Inc.", "effective": "", "evidence": "EDGAR reports a different company name for CIK 0001853921", "source_url": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001853921", "applied": 1, "detected_at": "2026-10-27T10:11:55.793170"}]}, "key_people": [{"who": "Behzad Aghazadeh", "who_key": "Aghazadeh Behzad", "role": "Director, 10% Owner", "person_type": "BOARD", "person_label": "Board", "bought": 36259761.25, "sold": 0, "net": 36259761.25, "trades": 1, "top_score": 84.7, "lean": "buying", "history": [{"action": "BUY", "amount": 36259761.25, "date": "2026-07-28", "score": 84.7, "source_url": "https://www.sec.gov/Archives/edgar/data/1853921/000090266426003270/0000902664-26-003270-index.htm"}], "latest": {"action": "BUY", "amount": 36259761.25, "date": "2026-07-28", "score": 84.7, "source_url": "https://www.sec.gov/Archives/edgar/data/1853921/000090266426003270/0000902664-26-003270-index.htm"}}, {"who": "Orbimed Advisors LLC", "who_key": "ORBIMED ADVISORS LLC", "role": "Director", "person_type": "BOARD", "person_label": "Board", "bought": 15000000.0, "sold": 0, "net": 15000000.0, "trades": 1, "top_score": 80.1, "lean": "buying", "history": [{"action": "BUY", "amount": 15000000.0, "date": "2026-07-27", "score": 80.1, "source_url": "https://www.sec.gov/Archives/edgar/data/1853921/000094787126000733/0000947871-26-000733-index.htm"}], "latest": {"action": "BUY", "amount": 15000000.0, "date": "2026-07-27", "score": 80.1, "source_url": "https://www.sec.gov/Archives/edgar/data/1853921/000094787126000733/0000947871-26-000733-index.htm"}}, {"who": "Carl L. Gordon", "who_key": "GORDON CARL L", "role": "Director", "person_type": "BOARD", "person_label": "Board", "bought": 15000000.0, "sold": 0, "net": 15000000.0, "trades": 1, "top_score": 80.1, "lean": "buying", "history": [{"action": "BUY", "amount": 15000000.0, "date": "2026-07-27", "score": 80.1, "source_url": "https://www.sec.gov/Archives/edgar/data/1853921/000094787126000734/0000947871-26-000734-index.htm"}], "latest": {"action": "BUY", "amount": 15000000.0, "date": "2026-07-27", "score": 80.1, "source_url": "https://www.sec.gov/Archives/edgar/data/1853921/000094787126000734/0000947871-26-000734-index.htm"}}, {"who": "AH Bio Fund II, L.P.", "who_key": "AH Bio Fund II, L.P.", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "bought": 4999995.0, "sold": 0, "net": 4999995.0, "trades": 1, "top_score": 59.3, "lean": "buying", "history": [{"action": "BUY", "amount": 4999995.0, "date": "2026-07-27", "score": 59.3, "source_url": "https://www.sec.gov/Archives/edgar/data/1853921/000123191926000813/0001231919-26-000813-index.htm"}], "latest": {"action": "BUY", "amount": 4999995.0, "date": "2026-07-27", "score": 59.3, "source_url": "https://www.sec.gov/Archives/edgar/data/1853921/000123191926000813/0001231919-26-000813-index.htm"}}, {"who": "Svetlana Lucas", "who_key": "Lucas Svetlana", "role": "Chief Business Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "bought": 45000.0, "sold": 0, "net": 45000.0, "trades": 1, "top_score": 38.7, "lean": "buying", "history": [{"action": "BUY", "amount": 45000.0, "date": "2026-07-23", "score": 38.7, "source_url": "https://www.sec.gov/Archives/edgar/data/1853921/000178129226000007/0001781292-26-000007-index.htm"}], "latest": {"action": "BUY", "amount": 45000.0, "date": "2026-07-23", "score": 38.7, "source_url": "https://www.sec.gov/Archives/edgar/data/1853921/000178129226000007/0001781292-26-000007-index.htm"}}, {"who": "David Parrot", "who_key": "Parrot David", "role": "Chief Financial Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "bought": 39990.0, "sold": 0, "net": 39990.0, "trades": 1, "top_score": 41.9, "lean": "buying", "history": [{"action": "BUY", "amount": 39990.0, "date": "2026-07-23", "score": 41.9, "source_url": "https://www.sec.gov/Archives/edgar/data/1853921/000212790826000004/0002127908-26-000004-index.htm"}], "latest": {"action": "BUY", "amount": 39990.0, "date": "2026-07-23", "score": 41.9, "source_url": "https://www.sec.gov/Archives/edgar/data/1853921/000212790826000004/0002127908-26-000004-index.htm"}}], "activity": [], "announcements": [{"form": "SCHEDULE 13G", "date": "2026-08-03", "title": "Form SCHEDULE 13G", "accession": "0001346824-26-000210", "price_sensitive": false}, {"form": "SCHEDULE 13D", "date": "2026-07-30", "title": "Form SCHEDULE 13D", "accession": "0000902664-26-003281", "price_sensitive": false}, {"form": "SCHEDULE 13D", "date": "2026-07-30", "title": "Form SCHEDULE 13D", "accession": "0000059478-26-000072", "price_sensitive": false}, {"form": "4", "date": "2026-07-29", "title": "Insider transaction", "accession": "0001231919-26-000813", "price_sensitive": false}, {"form": "4", "date": "2026-07-29", "title": "Insider transaction", "accession": "0000947871-26-000734", "price_sensitive": false}, {"form": "4", "date": "2026-07-29", "title": "Insider transaction", "accession": "0000947871-26-000733", "price_sensitive": false}, {"form": "SCHEDULE 13D", "date": "2026-07-29", "title": "Form SCHEDULE 13D", "accession": "0000947871-26-000732", "price_sensitive": false}, {"form": "4", "date": "2026-07-29", "title": "Insider transaction", "accession": "0001739090-26-000010", "price_sensitive": false}, {"form": "4", "date": "2026-07-28", "title": "Insider transaction", "accession": "0000902664-26-003270", "price_sensitive": false}, {"form": "4", "date": "2026-07-28", "title": "Insider transaction", "accession": "0002147277-26-000003", "price_sensitive": false}, {"form": "4", "date": "2026-07-27", "title": "Insider transaction", "accession": "0001781292-26-000007", "price_sensitive": false}, {"form": "4", "date": "2026-07-27", "title": "Insider transaction", "accession": "0002127814-26-000004", "price_sensitive": false}, {"form": "4", "date": "2026-07-27", "title": "Insider transaction", "accession": "0001282930-26-000004", "price_sensitive": false}, {"form": "4", "date": "2026-07-27", "title": "Insider transaction", "accession": "0002130384-26-000004", "price_sensitive": false}, {"form": "4", "date": "2026-07-27", "title": "Insider transaction", "accession": "0002075052-26-000004", "price_sensitive": false}, {"form": "4", "date": "2026-07-27", "title": "Insider transaction", "accession": "0002127908-26-000004", "price_sensitive": false}, {"form": "4", "date": "2026-07-27", "title": "Insider transaction", "accession": "0000902664-26-003254", "price_sensitive": false}, {"form": "8-K", "date": "2026-07-27", "title": "Material event", "accession": "0001193125-26-318263", "price_sensitive": true}, {"form": "S-8", "date": "2026-07-27", "title": "Employee share plan", "accession": "0001193125-26-316529", "price_sensitive": false}, {"form": "424B4", "date": "2026-07-27", "title": "Form 424B4", "accession": "0001193125-26-316503", "price_sensitive": false}, {"form": "FWP", "date": "2026-07-24", "title": "Form FWP", "accession": "0001193125-26-314757", "price_sensitive": false}, {"form": "EFFECT", "date": "2026-07-23", "title": "Form EFFECT", "accession": "9999999995-26-002417", "price_sensitive": false}, {"form": "3", "date": "2026-07-23", "title": "Initial insider holdings", "accession": "0001193125-26-314787", "price_sensitive": false}, {"form": "3", "date": "2026-07-23", "title": "Initial insider holdings", "accession": "0000947871-26-000715", "price_sensitive": false}, {"form": "3", "date": "2026-07-23", "title": "Initial insider holdings", "accession": "0001231919-26-000795", "price_sensitive": false}], "performance": {"ticker": "SCTX", "has_prices": true, "summary": {"n": 6, "avg": 0.3255414340030322, "win_rate": 1.0, "best": 0.43964562569213744, "worst": 0.20092378752886844, "as_of": "2026-08-07"}, "buys": [{"who": "Aghazadeh Behzad", "person_type": "BOARD", "person_label": "Board", "role": "Director, 10% Owner", "amount": 36259761.25, "date": "2026-07-28", "score": 84.7, "ref_price": 18.06, "return": 0.43964562569213744}, {"who": "ORBIMED ADVISORS LLC", "person_type": "BOARD", "person_label": "Board", "role": "Director", "amount": 15000000.0, "date": "2026-07-27", "score": 80.1, "ref_price": 18.97, "return": 0.37058513442277285}, {"who": "GORDON CARL L", "person_type": "BOARD", "person_label": "Board", "role": "Director", "amount": 15000000.0, "date": "2026-07-27", "score": 80.1, "ref_price": 18.97, "return": 0.37058513442277285}, {"who": "AH Bio Fund II, L.P.", "person_type": "TEN_PCT", "person_label": "10% Owners", "role": "10% Owner", "amount": 4999995.0, "date": "2026-07-27", "score": 59.3, "ref_price": 18.97, "return": 0.37058513442277285}, {"who": "Parrot David", "person_type": "C_SUITE", "person_label": "C-Suite", "role": "Chief Financial Officer", "amount": 39990.0, "date": "2026-07-23", "score": 41.9, "ref_price": 21.65, "return": 0.20092378752886844}, {"who": "Lucas Svetlana", "person_type": "C_SUITE", "person_label": "C-Suite", "role": "Chief Business Officer", "amount": 45000.0, "date": "2026-07-23", "score": 38.7, "ref_price": 21.65, "return": 0.20092378752886844}]}, "price_series": [{"date": "2026-07-24", "close": 21.65, "volume": 990795.0}, {"date": "2026-07-27", "close": 18.97, "volume": 419109.0}, {"date": "2026-07-28", "close": 18.06, "volume": 428607.0}, {"date": "2026-07-29", "close": 18.36, "volume": 325109.0}, {"date": "2026-07-30", "close": 20.4, "volume": 149266.0}, {"date": "2026-07-31", "close": 19.48, "volume": 100204.0}, {"date": "2026-08-03", "close": 20.835, "volume": 99114.0}, {"date": "2026-08-04", "close": 22.06, "volume": 149962.0}, {"date": "2026-08-05", "close": 23.8, "volume": 266587.0}, {"date": "2026-08-06", "close": 25.41, "volume": 193083.0}, {"date": "2026-08-07", "close": 26.0, "volume": 120180.0}], "refreshing": true}